Scientific Drug Safety Information for Patients' Consent
نویسندگان
چکیده
منابع مشابه
[Scientific drug safety information for patients' consent].
One of the important roles of pharmacists is to continue their contributions to new drug discovery and development. However, it seems to be very difficult to obtain patient satisfaction with new drugs. Because new medicines have both benefit and risk, there should be many systems to maximize the safety and efficacy of the drugs. In clinical trials, the rights, safety and welfare of human subjec...
متن کامل[Information technology for ensuring drug safety].
In Japan, information technology (IT) in the medical field has prevailed as a means for handling claims for health insurance reimbursement. In contrast, IT is primarily used for electronic medical records in Western countries. Originally, preparation of health insurance claims was one of the outcomes of computerized medical information in Japan. As its protocols are already well established in ...
متن کامل[Psychoactive drug advertising: analysis of scientific information].
OBJECTIVE According to the World Health Organization, medicinal drug promotion should be reliable, accurate, truthful, informative, balanced, up-to-date and capable of substantiation. The objective of the present study was to review psychoactive drug advertisements to physicians as for information consistency with the related references and accessibility of the cited references. METHODS Data ...
متن کاملPharmacogenetic information for patients on drug labels
Advances in pharmacogenetic research have improved our understanding of adverse drug responses and have led to the development of pharmacogenetic tests and targeted drugs. However, the extent of the communication process and provision of information to patients about pharmacogenetics is unclear. Pharmacogenetic information may be included in sections of a drug's package insert intended for pati...
متن کاملPatients' evaluation of informed consent to postponed information: cohort study.
Fundamental bias can be introduced in randomised trials if patients cannot be masked for the allocated strategy and assess subjective outcomes. In such a trial, on the effectiveness of outreach stroke care in addition to standard care, we masked patients by modifying the informed consent procedure. Before discharge home we informed patients that we were studying their needs six months after dis...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: YAKUGAKU ZASSHI
سال: 2011
ISSN: 0031-6903,1347-5231
DOI: 10.1248/yakushi.131.871